341 related articles for article (PubMed ID: 25442333)
1. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study.
van der Pal HJ; van Dijk IW; Geskus RB; Kok WE; Koolen M; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC; van Dalen EC
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):213-22. PubMed ID: 25442333
[TBL] [Abstract][Full Text] [Related]
2. Valvular Dysfunction in Lymphoma Survivors Treated With Autologous Stem Cell Transplantation: A National Cross-Sectional Study.
Murbraech K; Wethal T; Smeland KB; Holte H; Loge JH; Holte E; Rösner A; Dalen H; Kiserud CE; Aakhus S
JACC Cardiovasc Imaging; 2016 Mar; 9(3):230-9. PubMed ID: 26897666
[TBL] [Abstract][Full Text] [Related]
3. Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?
Pourier MS; Mavinkurve-Groothuis AM; Loonen J; Bökkerink JP; Roeleveld N; Beer G; Bellersen L; Kapusta L
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27654133
[TBL] [Abstract][Full Text] [Related]
4. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
[TBL] [Abstract][Full Text] [Related]
5. High risk of symptomatic cardiac events in childhood cancer survivors.
van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study.
Mulrooney DA; Armstrong GT; Huang S; Ness KK; Ehrhardt MJ; Joshi VM; Plana JC; Soliman EZ; Green DM; Srivastava D; Santucci A; Krasin MJ; Robison LL; Hudson MM
Ann Intern Med; 2016 Jan; 164(2):93-101. PubMed ID: 26747086
[TBL] [Abstract][Full Text] [Related]
8. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
9. Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study.
Delgado V; Biermasz NR; van Thiel SW; Ewe SH; Marsan NA; Holman ER; Feelders RA; Smit JW; Bax JJ; Pereira AM
Clin Endocrinol (Oxf); 2012 Jul; 77(1):99-105. PubMed ID: 22211510
[TBL] [Abstract][Full Text] [Related]
10. Yield of screening echocardiograms during pediatric follow-up in survivors treated with anthracyclines and cardiotoxic radiation.
Spewak MB; Williamson RS; Mertens AC; Border WL; Meacham LR; Wasilewski-Masker KJ
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27966803
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?
Ramjaun A; AlDuhaiby E; Ahmed S; Wang L; Yu E; Nathan PC; Hodgson DC
Pediatr Blood Cancer; 2015 Dec; 62(12):2197-203. PubMed ID: 26146944
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
[TBL] [Abstract][Full Text] [Related]
13. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.
Hull MC; Morris CG; Pepine CJ; Mendenhall NP
JAMA; 2003 Dec; 290(21):2831-7. PubMed ID: 14657067
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.
Armstrong GT; Joshi VM; Ness KK; Marwick TH; Zhang N; Srivastava D; Griffin BP; Grimm RA; Thomas J; Phelan D; Collier P; Krull KR; Mulrooney DA; Green DM; Hudson MM; Robison LL; Plana JC
J Am Coll Cardiol; 2015 Jun; 65(23):2511-22. PubMed ID: 26065990
[TBL] [Abstract][Full Text] [Related]
15. Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study.
Wethal T; Lund MB; Edvardsen T; Fosså SD; Pripp AH; Holte H; Kjekshus J; Fosså A
Br J Cancer; 2009 Aug; 101(4):575-81. PubMed ID: 19623176
[TBL] [Abstract][Full Text] [Related]
16. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
17. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± Chemotherapy.
Bijl JM; Roos MM; van Leeuwen-Segarceanu EM; Vos JM; Bos WW; Biesma DH; Post MC
Am J Cardiol; 2016 Feb; 117(4):691-696. PubMed ID: 26772441
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic determination of the prevalence of primary myxomatous degeneration of the cardiac valves.
He Y; Guo Y; Li Z; Chen J; Kontos MC; Paulsen WH; Han J; Wang L; Gu X; Nixon JV
J Am Soc Echocardiogr; 2011 Apr; 24(4):399-404. PubMed ID: 21353473
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors.
Mulder RL; Kremer LC; Koot BG; Benninga MA; Knijnenburg SL; van der Pal HJ; Koning CC; Oldenburger F; Wilde JC; Taminiau JA; Caron HN; van Dalen EC
Eur J Cancer; 2013 Jan; 49(1):185-93. PubMed ID: 22901831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
